Section one: Contracting authority
one.1) Name and addresses
Birmingham Women's and Children's NHS Foundation Trust
Steelhouse Lane
Birmingham
B4 6NH
Country
United Kingdom
NUTS code
UKG3 - West Midlands
Internet address(es)
Main address
https://www.uhb.nhs.uk/home.htm
Buyer's address
https://nhs.bravosolution.co.uk/nhs_collaborative/web/login.html
one.3) Communication
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Pedigree Software Solution for The West Midlands Regional Clinical Genetics Service
Reference number
PROC.08.0289
two.1.2) Main CPV code
- 48180000 - Medical software package
two.1.3) Type of contract
Supplies
two.1.4) Short description
Birmingham Women's and Children's NHS Foundation Trust is seeking to engage with suppliers interested in its requirement for a Pedigree Software Solution for The West Midlands Regional Clinical Genetics Service.
Suppliers who are able to offer a solution relevant to this requirement are invited to express an interest and respond to a market engagement questionnaire. Further details on how to do this are contained within the additional information section of this notice
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 48100000 - Industry specific software package
- 48219300 - Administration software package
- 48814400 - Clinical information system
two.2.3) Place of performance
NUTS codes
- UKG3 - West Midlands
two.2.4) Description of the procurement
Birmingham Women's and Children's NHS Foundation Trust is seeking to engage with suppliers interested in its requirement for a Pedigree Software Solution for The West Midlands Regional Clinical Genetics Service.
The West Midlands Regional Clinical Genetics Service at Birmingham Women’s Hospital specialises in the diagnosis and management of conditions with a known or probable genetic origin. We are the largest Clinical Genetics Service in England. We shave over 100 members of staff, receiving over a 1000 referrals each month.
Within the cancer pathway our patients have been referred due to having a cancer diagnosis themselves or a relative having with cancer. Patients often get referred to us with the following questions.
• Am I or members of my family at an increased risk of developing cancer?
• Is there extra cancer screening?
• Are there any things I can do to reduce my risk?
• Can I have a genetic test?
• Inform their current treatment options.
To be able to answer these questions we need to make a full assessment of a patient’s family history which requires the patient to complete a family history form. The current family history form is paper-based the information provided in this form currently requires manual entry and/or updating by our admin & genetic counsellor staff. Once the family history has been received we use this to form a pedigree of the family. When all the available information has been sought, the clinical team use this data to calculate personal cancer risks by using specific cancer risk assessment tools to answer the questions above.
A digital solution is required to be able to streamline all the above and mitigate risks within the current process and outdated software currently in use.
Suppliers who are able to offer a solution relevant to this requirement are invited to express an interest and respond to a market engagement questionnaire. Further details on how to do this are contained within the additional information section of this notice.
This exercise is intended to provide potential bidders with the opportunity to review the Authority's draft specification and to provide information regarding the services they can offer that could meet these outline requirements. This builds on the Authority's commitment to engage with the market, by sharing information and seeking input from the market to enable us to develop the final specification and determine the appropriate route to market in a fair and transparent manner.
two.3) Estimated date of publication of contract notice
1 October 2021
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section six. Complementary information
six.3) Additional information
Suppliers wishing to participate in this market engagement exercise and express an interest in this requirement should respond to the questionnaire via the online form on the Bravo Portal by 13:00 on Wednesday 18th August 2021
Bravo reference of online form: pqq__28658 - Pedigree Software for the West Midlands Regional Genetics Service - Market Engagement
Direct link to response form: